Why would that even be a factor when Canacord's investment was based on the Psychedelic business?
If Revive was the only company that was approached with this deal then I would say yes, but they weren't and that IMO negated some of the leverage Revive had in the negotiations.
There were 7 other similar deals done, for now, with other companies that almost perfectly mirror the one Revive got.
That said, I'm almost 100% sure Canacord was aware of the Covid Trials, hence the reason they likely approached MF at this point.
As a startup company that has ZERO REVENUES, coming in and a host of projects that burns through cash, I'm not sure what MF was expected to do.
Canacord is out to make money for their clients, not to be charitable to companies such as Revive and as such the financing was always going to favor them.
Now it's all up to MF to put this money to good use by completing projects and/or advancing others that may have been delayed/shelved due to lack of financing.
All a net +ve from my perspective.
Market Data 
Markets 
